|
|||||
|
|
From mutational inactivation to aberrant gain‐of‐function: Unraveling the structural basis of mutant p53 oncogenic transition |
|
| Authors: | Fisayo A. Olotu Mahmoud E.S. Soliman |
| Affiliation: | 1. Molecular Modeling and Drug Design Research Group, School of Health Sciences, University of KwaZulu‐Natal, Westville Campus, Durban, South Africa;2. College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, FAMU, Tallahassee, Florida;3. Faculty of Pharmacy, Department of Pharmaceutical Organic Chemistry, Zagazig University, Zagazig, Egypt |
| Abstract: | |
| Keywords: | gain‐of‐function inactivation mutation oncogenic p53 tumorigenesis |